Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SRF388 |
Trade Name | |
Synonyms | SRF-388|SRF 388 |
Drug Descriptions |
SRF388 is a monoclonal antibody that binds to interleukin 27 (IL27) and inhibits downstream signaling, which potentially modulates immune response and inhibits tumor growth (Journal for ImmunoTherapy of Cancer Nov 2019, 7 (Suppl 1) 283, Abs nr: P805). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + Bevacizumab + SRF388 | Atezolizumab Bevacizumab SRF388 | 0 | 1 |
Pembrolizumab + SRF388 | Pembrolizumab SRF388 | 0 | 0 |
SRF388 | SRF388 | 0 | 1 |